|
|
||||||||

Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, U.K.
A 21.8 kbp region of the genome of variola major virus (strain Harvey), a virus that caused haemorrhagic-type smallpox, has been sequenced and shown to possess 96% nucleotide identity to the corresponding region of vaccinia virus, the smallpox vaccine. Overall the gene arrangement in the two viruses is highly similar and individual open reading frames (ORFs) display a high degree of amino acid identity, for instance 26 of the 32 variola virus ORFs have
90% identity with their vaccinia virus counterparts. A remarkable difference is the disruption of seven vaccinia virus ORFs into small fragments in variola virus. These include the variola virus homologue of vaccinia virus SalF2R, which encodes a protein related to C-type animal lectins, and SalF7L, which encodes an active 3
-hydroxysteroid dehydrogenase enzyme that contributes to vaccinia virus virulence. Upstream of the variola virus haemagglutinin gene there is a deletion of 1910 bp so that the equivalent of vaccinia virus gene SalF17R is truncated, and SalF16R, which shows amino acid similarity to the tumour necrosis factor receptor, is absent. The region sequenced includes the genes for thymidylate kinase and DNA ligase both of which are active in vaccinia virus and are highly conserved in variola virus. Other conserved ORFs with interesting homologies are those encoding profilin, superoxide dismutase and part of guanylate kinase. Two vaccinia virus genes encoding glycoproteins of the outer envelope of extracellular enveloped virus are also conserved in variola virus and this homology is likely to have contributed to the immunological protection which vaccinia virus evoked against smallpox. Lastly, there are multiple instances in which short oligonucleotide direct repeats flank a region absent from either variola or vaccinia virus.
Present address: MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Received 9 June 1992;
accepted 16 July 1992.
This article has been cited by other articles:
![]() |
P. M. Beard, G. C. Froggatt, and G. L. Smith Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model J. Gen. Virol., June 1, 2006; 87(6): 1521 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Laidlaw and M. A. Skinner Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of Fowlpox virus, with those of virulent American and European viruses J. Gen. Virol., February 1, 2004; 85(2): 305 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gubser, S. Hue, P. Kellam, and G. L. Smith Poxvirus genomes: a phylogenetic analysis J. Gen. Virol., January 1, 2004; 85(1): 105 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. T. Teoh, P. J. Walasek, and D. H. Evans Leporipoxvirus Cu,Zn-Superoxide Dismutase (SOD) Homologs Are Catalytically Inert Decoy Proteins That Bind Copper Chaperone for SOD J. Biol. Chem., August 29, 2003; 278(35): 33175 - 33184. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Reading, J. B. Moore, and G. L. Smith Steroid Hormone Synthesis by Vaccinia Virus Suppresses the Inflammatory Response to Infection J. Exp. Med., May 19, 2003; 197(10): 1269 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Smith, A. Vanderplasschen, and M. Law The formation and function of extracellular enveloped vaccinia virus J. Gen. Virol., December 1, 2002; 83(12): 2915 - 2931. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Rosengard, Y. Liu, Z. Nie, and R. Jimenez From the Cover: Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement PNAS, June 25, 2002; 99(13): 8808 - 8813. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gubser and G. L. Smith The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox J. Gen. Virol., April 1, 2002; 83(4): 855 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Price, D. C. Tscharke, and G. L. Smith The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence J. Gen. Virol., April 1, 2002; 83(4): 873 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gardner, D. C. Tscharke, P. C. Reading, and G. L. Smith Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model J. Gen. Virol., September 1, 2001; 82(9): 2083 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ng, D. C. Tscharke, P. C. Reading, and G. L. Smith The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence J. Gen. Virol., September 1, 2001; 82(9): 2095 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Almazan, D. C. Tscharke, and G. L. Smith The Vaccinia Virus Superoxide Dismutase-Like Protein (A45R) Is a Virion Component That Is Nonessential for Virus Replication J. Virol., August 1, 2001; 75(15): 7018 - 7029. [Abstract] [Full Text] |
||||
![]() |
M. Saraiva and A. Alcami CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses J. Virol., January 1, 2001; 75(1): 226 - 233. [Abstract] [Full Text] |
||||
![]() |
D. Wilcock, S. A. Duncan, P. Traktman, W.-H. Zhang, and G. L. Smith The vaccinia virus A40R gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface J. Gen. Virol., August 1, 1999; 80(8): 2137 - 2148. [Abstract] [Full Text] |
||||
![]() |
I. Husain, A. E. Tomkinson, W. A. Burkhart, M. B. Moyer, W. Ramos, Z. B. Mackey, J. M. Besterman, and J. Chen Purification and Characterization of DNA Ligase III from Bovine Testes J. Biol. Chem., April 21, 1995; 270(16): 9683 - 9690. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |